Programming Nature – Entrepreneurs turn synthetic biology into real dollars

Programming Nature – Entrepreneurs turn synthetic biology into real dollars

HomevlabvideosProgramming Nature – Entrepreneurs turn synthetic biology into real dollars
Programming Nature – Entrepreneurs turn synthetic biology into real dollars
ChannelPublish DateThumbnail & View CountDownload Video
Channel AvatarPublish Date not found Thumbnail
0 Views
When:
Tuesday January 22, 2013
Or:
Cemex Auditorium at Knight Management Center (parking and directions)

Description of the event:

Synthetic biology was once the domain of big pharmaceutical companies and the multi-million dollar chemical industry. But today, startups and hackers in their garages and basements are using cloud-based services and low-cost labs, tools and equipment to manipulate organisms to produce valuable materials and products. economic.

Startups like Lygos are modifying the DNA of yeast and e-coli to produce nylon, polyester and polypropylene for clothing. RefactoredMaterials transforms proteins to create materials that mimic spider silk. All of this is possible because cloud-based services and low-cost tools allow these companies to quickly and cost-effectively create and cycle through multiple DNA models to discover the right formula for producing these materials.

Come to our event on January 22, 2013 at the Stanford Graduate School of Business to discover:

What are the cloud tools and services that enable synthetic biology for startups?
What are the keys to low-cost innovation that will democratize synthetic biology and create profitable businesses?
How are movements like Biohacking and Biocurious helping to shape this new movement?
Can backyard biologists have the same impact as homebrew computer clubs in the 1980s?
Is there an equivalent to Moore's Law for this space and what do investors think are the next big opportunities?
Join us to learn more.

Moderator:

Megan Palmer, Deputy Director, Stanford University, Synthetic Biology Engineering Research Center (SynBERC)

Panelists:

Dan Widmaier, CEO, Refactored Materials

Nathan J. Hillson, Founder and Chief Scientific Officer, Teselagen

Warren Hogarth, Partner, Sequoia Capital

Sasha Kamb, Senior Vice President, Amgen

Please take the opportunity to connect and share this video with your friends and family if you find it useful.